Full text is available at the source.
Abstract
There are currently no available guidelines for switching from semaglutide to tirzepatide.
- Semaglutide and tirzepatide have different mechanisms of action.
- The pharmacokinetics of these two medications differ.
- Switching treatments may pose challenges for continuous obesity management.
Simplified